Gesundheit Österreich was commissioned by the Global AMR R&D Hub to conduct a study to inform national policy makers about options in addressing novel antibiotic and diagnostic pricing,…
We aim to contribute to affordable, equitable and sustainable access to safe, effective and quality essential medicines in Austria, Europe and globally.
Novel policy options for reimbursement, pricing and procurement of AMR health technologies
Assessment of centralised procurement of medicines in Portugal
Gesundheit Österreich conducted an assessment of the performance of centralised procurement of medicines (CPM) in Portugal. The study, commissioned by the Directorate-General REFORM of the European…
Online Summer School Pharmaceutical Pricing and Reimbursement Policies 2021
5-9 July 2021 The WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies is pleased to announce the first Online Summer School on Pharmaceutical Pricing and Reimbursement…